PACS Group Reports 31% Revenue Growth to $1.34 Billion in Latest Quarter

PACS Group, Inc. reported significant financial growth in its latest quarterly filing, with total revenue reaching $1.34 billion for the three months ended September 30, 2025, a 31% increase from $1.03 billion in the same period last year. The company's patient and resident service revenue, which constitutes the majority of its income, rose by 31.2% to $1.34 billion, driven primarily by a 22.7% increase in patient days. This growth was attributed to an increase in operational beds, which rose by 19% year-over-year, from 27,467 to 32,677. The net income for the quarter was $52.3 million, a substantial increase of 222.8% compared to $16.2 million in the prior year.

In comparison to the previous fiscal period, PACS Group's operating income surged to $86.3 million, up from $23 million, marking a 275.7% increase. The company also reported a notable reduction in interest expenses, which fell by 5.5% to $8.5 million. However, the overall operating expenses increased by 25.4% to $1.26 billion, largely due to rising costs in salaries and wages, which accounted for a significant portion of the increase in cost of services. General and administrative expenses also rose, reflecting higher legal costs associated with ongoing investigations.

Strategically, PACS Group expanded its operations by adding seven new facilities, which included five acquired through long-term leases and two previously owned properties. This expansion added 495 skilled nursing beds and 271 assisted living beds to its portfolio. The company now operates a total of 320 facilities across 17 states, serving over 31,100 patients daily. The average occupancy rate across all facilities was reported at 89%, a slight decline from 90.5% in the previous year, with mature facilities showing a marginal increase in occupancy.

The filing also highlighted challenges, including ongoing regulatory investigations and a material weakness in internal controls over financial reporting. The company is currently in a state of forbearance with its lenders regarding its Amended and Restated Credit Facility, which has restricted its ability to borrow additional funds. Despite these challenges, PACS Group maintains a positive outlook, with management expressing confidence in its operational strategies and the potential for continued growth in patient services revenue, particularly as it integrates newly acquired facilities and enhances operational efficiencies. The company believes its current cash reserves and operational cash flow will be sufficient to meet its needs for at least the next 12 months.